DrugFeb 1, 2017
Mylan LLC Temozolomide Capsules, 100 mg recall — FDA D-0441-2017
Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
Class IIFDA: TerminatedMylan LLC.
Recall history in this database
Classification mix: Class II: 3.
DrugFeb 1, 2017
Mylan LLC Temozolomide Capsules, 180 mg recall — FDA D-0443-2017
Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
Class IIFDA: TerminatedMylan LLC.
DrugFeb 1, 2017
Mylan LLC Temozolomide Capsules, 140 mg recall — FDA D-0442-2017
Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
Class IIFDA: TerminatedMylan LLC.
Understanding this recall history
This page summarizes recall records in which the official source identifies Mylan LLC. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.